产品编号 | 图片 | CAS No. | 名称及描述 | 规格 | 价格 | 分子式 | 快速订购 |
---|---|---|---|---|---|---|---|
GC33399-10mg |
|
221877-56-1 |
42-(2-Tetrazolyl)rapamycin - Glpbio |
0 | 需询价 | C52H79N5O12 | |
GC33399-5mg |
|
221877-56-1 |
42-(2-Tetrazolyl)rapamycin - Glpbio |
0 | 需询价 | C52H79N5O12 | |
GC33399-2mg |
|
221877-56-1 |
42-(2-Tetrazolyl)rapamycin - Glpbio |
0 | 需询价 | C52H79N5O12 | |
GC33399-1mg |
|
221877-56-1 |
42-(2-Tetrazolyl)rapamycin - Glpbio |
0 | 需询价 | C52H79N5O12 | |
GC33399-10mM(1mLinDMSO) |
|
221877-56-1 |
42-(2-Tetrazolyl)rapamycin - Glpbio |
0 | 需询价 | C52H79N5O12 | |
GC33398-25mg |
|
2097262-60-5 |
FASN inhibitor 1 - Glpbio |
0 | 需询价 | C24H24N4O | |
GC33398-10mg |
|
2097262-60-5 |
FASN inhibitor 1 - Glpbio |
0 | 需询价 | C24H24N4O | |
GC33398-5mg |
|
2097262-60-5 |
FASN inhibitor 1 - Glpbio |
0 | 需询价 | C24H24N4O | |
GC33396-100mg |
|
302-84-1 |
DL-Serine - Glpbio |
0 | 需询价 | C3H7NO3 | |
GC33394-100mg |
|
1639417-54-1 |
Tenalisib R Enantiomer (RP6530 R Enantiomer) - Glpbio |
0 | 需询价 | C23H18FN5O2 | |
GC33394-50mg |
|
1639417-54-1 |
Tenalisib R Enantiomer (RP6530 R Enantiomer) - Glpbio |
0 | 需询价 | C23H18FN5O2 | |
GC33394-25mg |
|
1639417-54-1 |
Tenalisib R Enantiomer (RP6530 R Enantiomer) - Glpbio |
0 | 需询价 | C23H18FN5O2 | |
GC33394-10mg |
|
1639417-54-1 |
Tenalisib R Enantiomer (RP6530 R Enantiomer) - Glpbio |
0 | 需询价 | C23H18FN5O2 | |
GC33394-5mg |
|
1639417-54-1 |
Tenalisib R Enantiomer (RP6530 R Enantiomer) - Glpbio |
0 | 需询价 | C23H18FN5O2 | |
GC33394-1mg |
|
1639417-54-1 |
Tenalisib R Enantiomer (RP6530 R Enantiomer) - Glpbio |
0 | 需询价 | C23H18FN5O2 | |
GC33394-10mM(1mLinDMSO) |
|
1639417-54-1 |
Tenalisib R Enantiomer (RP6530 R Enantiomer) - Glpbio |
0 | 需询价 | C23H18FN5O2 | |
GC33392-20mg |
|
1278405-51-8 |
CHK-IN-1 - Glpbio |
0 | 需询价 | C18H19ClFN5OS | |
GC33392-10mg |
|
1278405-51-8 |
CHK-IN-1 - Glpbio |
0 | 需询价 | C18H19ClFN5OS | |
GC33392-5mg |
|
1278405-51-8 |
CHK-IN-1 - Glpbio |
0 | 需询价 | C18H19ClFN5OS | |
GC33392-1mg |
|
1278405-51-8 |
CHK-IN-1 - Glpbio |
0 | 需询价 | C18H19ClFN5OS | |